These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
646 related items for PubMed ID: 3142593
1. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Ehsanullah RS, Page MC, Tildesley G, Wood JR. BMJ; 1988 Oct 22; 297(6655):1017-21. PubMed ID: 3142593 [Abstract] [Full Text] [Related]
2. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G, Lazzaroni M, Petrillo M. Am J Gastroenterol; 1997 Apr 22; 92(4):663-7. PubMed ID: 9128319 [Abstract] [Full Text] [Related]
3. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Bianchi Porro G, Lazzaroni M, Imbesi V, Montrone F, Santagada T. Dig Liver Dis; 2000 Apr 22; 32(3):201-8. PubMed ID: 10975769 [Abstract] [Full Text] [Related]
4. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI. N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582 [Abstract] [Full Text] [Related]
5. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Gut; 1991 Mar 30; 32(3):252-5. PubMed ID: 2013419 [Abstract] [Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage. Valentini M, Cannizzaro R, Poletti M, Bortolussi R, Fracasso A, Testa V, Sozzi M, Fornasarig M, Bortoluzzi F, Grazioli I. J Clin Oncol; 1995 Oct 30; 13(10):2637-42. PubMed ID: 7595718 [Abstract] [Full Text] [Related]
8. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Robinson MG, Griffin JW, Bowers J, Kogan FJ, Kogut DG, Lanza FL, Warner CW. Dig Dis Sci; 1989 Mar 30; 34(3):424-8. PubMed ID: 2646087 [Abstract] [Full Text] [Related]
9. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S. Scand J Gastroenterol; 1993 Oct 30; 28(10):875-8. PubMed ID: 8266016 [Abstract] [Full Text] [Related]
10. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Hawkey CJ, Wilson I, Naesdal J, Långström G, Swannell AJ, Yeomans ND. Gut; 2002 Sep 30; 51(3):344-50. PubMed ID: 12171954 [Abstract] [Full Text] [Related]
11. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases]. Simon B, Beckers KH, Biewer W, Bouzo MH, Dammann HG, Gebest HJ, Müller P, Schütz E. Z Gastroenterol; 1988 Jun 30; 26(6):310-3. PubMed ID: 3061183 [Abstract] [Full Text] [Related]
12. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G. Am J Gastroenterol; 1996 Nov 30; 91(11):2367-71. PubMed ID: 8931419 [Abstract] [Full Text] [Related]
13. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dajani EZ, Agrawal NM. Dig Dis; 1995 Jan 30; 13 Suppl 1():48-61. PubMed ID: 7697902 [Abstract] [Full Text] [Related]
14. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. ten Wolde S, Dijkmans BA, Janssen M, Hermans J, Lamers CB. Aliment Pharmacol Ther; 1996 Jun 30; 10(3):347-51. PubMed ID: 8791962 [Abstract] [Full Text] [Related]
15. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Hawkey CJ, Naesdal J, Wilson I, Långström G, Swannell AJ, Peacock RA, Yeomans ND. Gut; 2002 Sep 30; 51(3):336-43. PubMed ID: 12171953 [Abstract] [Full Text] [Related]
16. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Am J Gastroenterol; 1996 Feb 30; 91(2):223-7. PubMed ID: 8607484 [Abstract] [Full Text] [Related]
17. Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. Sikes DH, Agrawal NM, Zhao WW, Kent JD, Recker DP, Verburg KM. Eur J Gastroenterol Hepatol; 2002 Oct 30; 14(10):1101-11. PubMed ID: 12362101 [Abstract] [Full Text] [Related]
18. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R, Tindall E, Triadafilopoulos G, Stromatt SC, Teoh LS. Ann Intern Med; 1993 Aug 15; 119(4):257-62. PubMed ID: 8328732 [Abstract] [Full Text] [Related]
19. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs. Tildesley G, Ehsanullah RS, Wood JR. Br J Rheumatol; 1993 Jun 15; 32(6):474-8. PubMed ID: 8508283 [Abstract] [Full Text] [Related]
20. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. Clin Ther; 2006 Mar 15; 28(3):340-51. PubMed ID: 16750449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]